CABOMETYX® IS INDICATED FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA (aRCC):

– In treatment-naïve adults with intermediate or poor risk
– In adults following prior vascular endothelial growth factor (VEGF)-targeted therapy

CABOMETYX® IN YOUR COUNTRY

Welcome to the EU website of Cabometyx®. Get access to local Cabometyx® info in your country: